Southern Acids (M) Berhad Gestion

Gestion contrôle des critères 3/4

Le PDG Southern Acids (M) Berhad est Nick Low, nommé en Jul2015, a un mandat de 9.33 ans. La rémunération annuelle totale est MYR 941.88K, composée du salaire de 54.4% et des bonus 45.6%, y compris les actions et options de la société. détient directement 0.069% des actions de la société, d'une valeur de MYR 292.18K. La durée moyenne de mandat de l'équipe de direction et du conseil d'administration est respectivement 11.1 ans et 9.8 ans.

Informations clés

Nick Low

Directeur général

RM 941.9k

Rémunération totale

Pourcentage du salaire du PDG	54.4%
Durée du mandat du directeur général	9.3yrs
Propriété du PDG	0.07%
Durée moyenne d'occupation des postes de direction	11.1yrs
Durée moyenne du mandat des membres du conseil d'administration	9.8yrs

Mises à jour récentes de la gestion

Recent updates

Southern Acids (M) Berhad's (KLSE:SAB) Soft Earnings Are Actually Better Than They Appear

Mar 03

If You Like EPS Growth Then Check Out Southern Acids (M) Berhad (KLSE:SAB) Before It's Too Late

May 27

The Returns At Southern Acids (M) Berhad (KLSE:SAB) Aren't Growing

Apr 19

Are Strong Financial Prospects The Force That Is Driving The Momentum In Southern Acids (M) Berhad's KLSE:SAB) Stock?

Feb 24

Returns On Capital At Southern Acids (M) Berhad (KLSE:SAB) Paint An Interesting Picture

Jan 13

What Can We Learn About Southern Acids (M) Berhad's (KLSE:SAB) CEO Compensation?

Dec 15

Southern Acids (M) Berhad (KLSE:SAB) Share Prices Have Dropped 14% In The Last Three Years

Nov 24

Analyse de la rémunération des PDG

Comment la rémunération de Nick Low a-t-elle évolué par rapport aux bénéfices de Southern Acids (M) Berhad?
Date	Rémunération totale	Salaire	Bénéfices de l'entreprise
Jun 30 2024	n/a	n/a	RM 6m
Mar 31 2024	RM 942k	RM 512k	RM 14m
Dec 31 2023	n/a	n/a	-RM 1m
Sep 30 2023	n/a	n/a	RM 11m
Jun 30 2023	n/a	n/a	RM 28m
Mar 31 2023	RM 927k	RM 505k	RM 33m
Dec 31 2022	n/a	n/a	RM 69m
Sep 30 2022	n/a	n/a	RM 80m
Jun 30 2022	n/a	n/a	RM 86m
Mar 31 2022	RM 874k	RM 463k	RM 94m
Dec 31 2021	n/a	n/a	RM 74m
Sep 30 2021	n/a	n/a	RM 53m
Jun 30 2021	n/a	n/a	RM 44m
Mar 31 2021	RM 727k	RM 421k	RM 37m
Dec 31 2020	n/a	n/a	RM 40m
Sep 30 2020	n/a	n/a	RM 44m
Jun 30 2020	n/a	n/a	RM 44m
Mar 31 2020	RM 712k	RM 414k	RM 32m
Dec 31 2019	n/a	n/a	RM 24m
Sep 30 2019	n/a	n/a	RM 19m
Jun 30 2019	n/a	n/a	RM 19m
Mar 31 2019	RM 699k	RM 390k	RM 21m
Dec 31 2018	n/a	n/a	RM 29m
Sep 30 2018	n/a	n/a	RM 35m
Jun 30 2018	n/a	n/a	RM 32m
Mar 31 2018	RM 649k	RM 366k	RM 33m

Rémunération vs marché: La rémunération totale de Nick ($USD 210.95K ) est supérieure à la moyenne des entreprises de taille similaire sur le marché MY ($USD 108.48K ).

Rémunération et revenus: La rémunération de Nick a été cohérente avec les performances de l'entreprise au cours de l'année écoulée.

PDG

Nick Low (45 yo)

9.3yrs

Titularisation

RM 941,877

Compensation

Dr. Kok Thye Low , also known as Nick, has been Managing Director and Director of Southern Acids M Bhd since July 2015. Dr. Low served as a Director In-Lead of Oleochemical and Health Care Divisions at Sou...

Équipe de direction

Nom	Position	Titularisation	Compensation	Propriété
Kok Low	MD & Non-Independent Executive Director	9.3yrs	RM 941.88k	0.069% MYR 292.2k
Kim Lim	Non-Independent Executive Director	16.3yrs	RM 759.05k	2.32% MYR 9.8m
Kee Cheong	Chief Financial Officer	11.1yrs	pas de données	pas de données
Thevakumar Kaliaperumal	General Manager of Operations	1.8yrs	pas de données	pas de données
Chuu Tiong	Chief Operating Officer of Oleochemical Manufacturing Segment	13.8yrs	pas de données	pas de données
Choon Chan	Chief Strategic Development Officer	no data	pas de données	pas de données
Kui Lim	Company Secretary	16.3yrs	pas de données	pas de données
Shu Ng	Company Secretary	1.7yrs	pas de données	pas de données

11.1yrs

Durée moyenne de l'emploi

54.5yo

Âge moyen

Gestion expérimentée: L'équipe dirigeante de SAB est chevronnée et expérimentée (11.1 années d'ancienneté moyenne).

Membres du conseil d'administration

Nom	Position	Titularisation	Compensation	Propriété
Kok Low	MD & Non-Independent Executive Director	9.3yrs	RM 941.88k	0.069% MYR 292.2k
Kim Lim	Non-Independent Executive Director	19.3yrs	RM 759.05k	2.32% MYR 9.8m
Kin Chung	Non Independent Non Executive Director	12.7yrs	RM 150.45k	pas de données
Sulong bin Matjeraie	Independent Non-Executive Chairman	10.3yrs	RM 151.80k	pas de données
Yeng Wan	Independent & Non Executive Director	1.7yrs	RM 104.95k	pas de données
Deborah Choa	Independent Non-Executive Director	1.3yrs	RM 55.38k	pas de données

9.8yrs

Durée moyenne de l'emploi

57yo

Âge moyen

Conseil d'administration expérimenté: Les membres du conseil d'administration de SAB sont considérés comme expérimentés (ancienneté moyenne 9.8 ans).

Southern Acids (M) Berhad Gestion

Gestion contrôle des critères 3/4

Informations clés

Mises à jour récentes de la gestion

Southern Acids (M) Berhad, Annual General Meeting, Aug 26, 2024

Southern Acids (M) Berhad Announces Redesignation of Chung Kin Mun from Independent Director to Non Independent and Non Executive Director

Southern Acids (M) Berhad Announces Redesignation of Stephen Wan Yeng Leong from Member of Audit Committee to Independent and Non Executive Chairman of Audit Committee

Southern Acids (M) Berhad Announces Appointment of Deborah Deb-Bie Choa as Independent and Non Executive Director

Southern Acids (M) Berhad, Annual General Meeting, Aug 30, 2023

Southern Acids (M) Berhad Announces Cessation of Office of Madam Leong So Seh as Member of Nomination and Remuneration Committee

Recent updates

New minor risk - Market cap size

Upcoming dividend of RM0.05 per share

New major risk - Revenue and earnings growth

Full year 2024 earnings released: EPS: RM0.10 (vs RM0.24 in FY 2023)

Southern Acids (M) Berhad, Annual General Meeting, Aug 26, 2024

New minor risk - Market cap size

Full year 2024 earnings released: EPS: RM0.10 (vs RM0.24 in FY 2023)

Southern Acids (M) Berhad Announces Redesignation of Chung Kin Mun from Independent Director to Non Independent and Non Executive Director

Third quarter 2024 earnings released: EPS: RM0.033 (vs RM0.12 in 3Q 2023)

Southern Acids (M) Berhad Announces Redesignation of Stephen Wan Yeng Leong from Member of Audit Committee to Independent and Non Executive Chairman of Audit Committee

Southern Acids (M) Berhad (KLSE:SAB) entered into agreement to acquire remaining 10% stake in Firstview Development Sdn Bhd from Low Mong Hua Sdn Berhad for RM 23.5 million.

Second quarter 2024 earnings released: RM0.039 loss per share (vs RM0.081 profit in 2Q 2023)

Upcoming dividend of RM0.05 per share at 1.5% yield

Southern Acids (M) Berhad Announces Appointment of Deborah Deb-Bie Choa as Independent and Non Executive Director

First quarter 2024 earnings released: EPS: RM0.067 (vs RM0.11 in 1Q 2023)

New minor risk - Market cap size

Full year 2023 earnings released: EPS: RM0.24 (vs RM0.69 in FY 2022)

Southern Acids (M) Berhad, Annual General Meeting, Aug 30, 2023

Southern Acids (M) Berhad Announces Cessation of Office of Madam Leong So Seh as Member of Nomination and Remuneration Committee

Full year 2023 earnings released: EPS: RM0.24 (vs RM0.69 in FY 2022)

Outhern Acids (M) Berhad Recommends Single Tier Final Dividend in Respect of the Financial Year Ended 31 March 2023

Southern Acids (M) Berhad's (KLSE:SAB) Soft Earnings Are Actually Better Than They Appear

Third quarter 2023 earnings released: EPS: RM0.12 (vs RM0.20 in 3Q 2022)

Second quarter 2023 earnings released: EPS: RM0.082 (vs RM0.13 in 2Q 2022)

Price target decreased to RM3.40

Insufficient new directors

Upcoming dividend of RM0.05 per share

Full year 2022 earnings released: EPS: RM0.69 (vs RM0.27 in FY 2021)

Southern Acids (M) Berhad Announces Final Dividend, Payable on 28 Nov. 2022

Southern Acids (M) Berhad Recommends Single Tier Final Dividend for the Financial Year Ended March 31, 2022

Full year 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Price target decreased to RM3.40

Insufficient new directors

Third quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Second quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

First quarter 2022 earnings released: EPS RM0.17 (vs RM0.13 in 1Q 2021)

Upcoming dividend of RM0.05 per share

Full year 2021 earnings released: EPS RM0.27 (vs RM0.23 in FY 2020)

Price target decreased to RM3.40

Full year 2021 earnings released: EPS RM0.27 (vs RM0.23 in FY 2020)

If You Like EPS Growth Then Check Out Southern Acids (M) Berhad (KLSE:SAB) Before It's Too Late

Southern Acids (M) Berhad Recommends Final Dividend for the Year Ended March 31, 2021

The Returns At Southern Acids (M) Berhad (KLSE:SAB) Aren't Growing

Third quarter 2021 earnings released: EPS RM0.041 (vs RM0.076 in 3Q 2020)

Are Strong Financial Prospects The Force That Is Driving The Momentum In Southern Acids (M) Berhad's KLSE:SAB) Stock?

Returns On Capital At Southern Acids (M) Berhad (KLSE:SAB) Paint An Interesting Picture

What Can We Learn About Southern Acids (M) Berhad's (KLSE:SAB) CEO Compensation?

New 90-day high: RM3.88

Southern Acids (M) Berhad Announces Appointment of Tan Sri Datuk Seri Panglima Sulong Bin Matjeraie as Independent and Non Executive Ember of Audit Committee

Second quarter 2021 earnings released: EPS RM0.06

Southern Acids (M) Berhad (KLSE:SAB) Share Prices Have Dropped 14% In The Last Three Years

New 90-day high: RM3.80

Southern Acids (M) Berhad Announces the Resignation of Encik Teo Leng as Independent and Non Executive Member of Audit Committee

New 90-day high: RM3.72

Upcoming Dividend of RM0.05 Per Share

First quarter earnings released

New 90-day high - RM3.68

Analyse de la rémunération des PDG

PDG

Titularisation

Compensation

Équipe de direction

Durée moyenne de l'emploi

Âge moyen

Membres du conseil d'administration

Durée moyenne de l'emploi

Âge moyen